New England Compounding Center

Form 483 issued October 26, 2012 · Framingham, Massachusetts

Inspection
Oct 1 – Oct 26, 2012
Investigator
Philip Kreiter
Observations
5
Pages
8
FEI number
3003623877

In short: On October 26, 2012, FDA issued a Form 483 with 5 observations to New England Compounding Center in Framingham, Massachusetts (FEI 3003623877) after an inspection that ran Oct 1 – Oct 26, 2012. The investigator was Philip Kreiter. Most observations concern production and facilities & equipment; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

Production and facilities & equipment account for 2 of 2 observations.

Production1
Facilities & equipment1

Most cited: 21 CFR 211.113 (1×) · 211.67 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The environmental monitoring procedure requires sampling via personnel touch plates taken upon completion of sterile compounding…

  2. 02

    The conditions listed below were identified during the inspection in areas used for the preparation, fi…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at New England Compounding Center?

FDA listed 5 observations on this Form 483, mostly about production and facilities & equipment. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected New England Compounding Center?

Philip Kreiter is named on this Form 483, for the inspection of Oct 1 – Oct 26, 2012. Each investigator has a profile showing what they cite most.

When was New England Compounding Center inspected by FDA?

The inspection ran Oct 1 – Oct 26, 2012, and the Form 483 is dated October 26, 2012.

How do I get the full Form 483 for New England Compounding Center?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free